SE500603C2 - Terapeutiska ringar - Google Patents
Terapeutiska ringarInfo
- Publication number
- SE500603C2 SE500603C2 SE8802675A SE8802675A SE500603C2 SE 500603 C2 SE500603 C2 SE 500603C2 SE 8802675 A SE8802675 A SE 8802675A SE 8802675 A SE8802675 A SE 8802675A SE 500603 C2 SE500603 C2 SE 500603C2
- Authority
- SE
- Sweden
- Prior art keywords
- core
- extruded
- composition
- casing
- crosslinking
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 40
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 34
- 238000004132 cross linking Methods 0.000 claims abstract description 28
- 239000003814 drug Substances 0.000 claims abstract description 27
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 24
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 238000001125 extrusion Methods 0.000 claims description 9
- 238000005520 cutting process Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- 238000005304 joining Methods 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000003377 silicon compounds Chemical class 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 2
- 238000004873 anchoring Methods 0.000 claims description 2
- 229960005309 estradiol Drugs 0.000 claims description 2
- 229930182833 estradiol Natural products 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims 1
- 229920002379 silicone rubber Polymers 0.000 abstract description 5
- 239000004945 silicone rubber Substances 0.000 abstract description 4
- 238000013270 controlled release Methods 0.000 abstract 1
- -1 alkyl hydrogen Chemical compound 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 230000029142 excretion Effects 0.000 description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- QYLFHLNFIHBCPR-UHFFFAOYSA-N 1-ethynylcyclohexan-1-ol Chemical compound C#CC1(O)CCCCC1 QYLFHLNFIHBCPR-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KLFRPGNCEJNEKU-FDGPNNRMSA-L (z)-4-oxopent-2-en-2-olate;platinum(2+) Chemical compound [Pt+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O KLFRPGNCEJNEKU-FDGPNNRMSA-L 0.000 description 1
- ZKFNOUUKULVDOB-UHFFFAOYSA-N 1-amino-1-phenylmethyl phosphonic acid Chemical compound OP(=O)(O)C(N)C1=CC=CC=C1 ZKFNOUUKULVDOB-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003060 catalysis inhibitor Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 description 1
- 229960004616 medroxyprogesterone Drugs 0.000 description 1
- 229960003846 melengestrol acetate Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 239000012974 tin catalyst Substances 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 229940044953 vaginal ring Drugs 0.000 description 1
- 239000006213 vaginal ring Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1002—Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
- Y10T156/1036—Bending of one piece blank and joining edges to form article
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
- Y10T156/1062—Prior to assembly
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8710363A FR2618329B1 (fr) | 1987-07-22 | 1987-07-22 | Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8802675D0 SE8802675D0 (sv) | 1988-07-19 |
| SE8802675L SE8802675L (sv) | 1989-01-23 |
| SE500603C2 true SE500603C2 (sv) | 1994-07-25 |
Family
ID=9353424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8802675A SE500603C2 (sv) | 1987-07-22 | 1988-07-19 | Terapeutiska ringar |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4888074A (OSRAM) |
| JP (1) | JP2755392B2 (OSRAM) |
| CA (1) | CA1298688C (OSRAM) |
| CH (1) | CH675964A5 (OSRAM) |
| DE (1) | DE3824853C2 (OSRAM) |
| DK (1) | DK171154B1 (OSRAM) |
| ES (1) | ES2009987A6 (OSRAM) |
| FR (1) | FR2618329B1 (OSRAM) |
| GB (1) | GB2207355B (OSRAM) |
| IT (1) | IT1223709B (OSRAM) |
| SE (1) | SE500603C2 (OSRAM) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5238679A (en) * | 1987-02-26 | 1993-08-24 | Rhone-Poulenc Chimie | Diorganopolysiloxane dosage forms for the controlled release of iodine values |
| US5141748A (en) * | 1989-02-17 | 1992-08-25 | Hoffmann-La Roche, Inc. | Implant drug delivery device |
| US5181505A (en) * | 1989-03-08 | 1993-01-26 | Lew Chel W | Method and apparatus for delivery of a medicament in the oral cavity |
| US5130137A (en) * | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
| US5683719A (en) * | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
| JP3107575B2 (ja) * | 1990-12-29 | 2000-11-13 | 株式会社ブリヂストン | 環状部材の成形装置および成形方法 |
| US5756035A (en) * | 1991-08-01 | 1998-05-26 | Polymedica Industries, Inc. | Method of making an access graft and a vascular prosthesis |
| USD350601S (en) | 1991-12-19 | 1994-09-13 | The Upjohn Company | Vaginal drug delivery insert |
| US5582591A (en) * | 1994-09-02 | 1996-12-10 | Delab | Delivery of solid drug compositions |
| US5837276A (en) * | 1994-09-02 | 1998-11-17 | Delab | Apparatus for the delivery of elongate solid drug compositions |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| FR2745180B1 (fr) * | 1996-02-23 | 1998-05-07 | Dow Corning Sa | Procede de fabrication de dispositifs a liberation controlee |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| FR2766088B1 (fr) * | 1997-07-17 | 2001-01-05 | Dow Corning Sa | Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire |
| US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| JP2002513690A (ja) | 1998-05-01 | 2002-05-14 | エフイ−アイ エンタープライジズ，リミティド | 制御放出デバイスの射出成形製造方法 |
| DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| AU4483100A (en) | 1999-04-23 | 2000-11-10 | Situs Corporation | Pressure responsive valve for use with an intravesical infuser |
| US6689297B1 (en) * | 2000-02-22 | 2004-02-10 | Uchiyama Manufacturing Corp. | Method of manufacturing magnetic rubber ring |
| US6503190B1 (en) | 2000-09-29 | 2003-01-07 | Ethicon Endo-Surgery, Inc. | Vaginal pessary |
| CA2442281C (en) * | 2001-03-27 | 2010-06-08 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| CN1210079C (zh) * | 2001-04-25 | 2005-07-13 | 上海市计划生育科学研究所 | 阴道环制剂及其应用 |
| AR026386A1 (es) * | 2001-10-24 | 2003-02-12 | Massara Julio Eduardo | Un dispositivo intravaginal que contiene progesterona, util como inductor de celo en bovinos productores de carne y leche, y el procedimiento paraprepararlo |
| WO2003080019A1 (en) * | 2002-03-27 | 2003-10-02 | Galen (Chemicals) Limited | Intravaginal reservoir drug delivery devices |
| CA2531640C (en) * | 2003-07-10 | 2013-06-18 | Galen (Chemicals) Limited | Intravaginal drug delivery devices |
| US20060246389A1 (en) * | 2005-05-02 | 2006-11-02 | Saint-Gobain Ceramics & Plastics, Inc. | Ceramic article, ceramic extrudate and related articles |
| US20060244173A1 (en) * | 2005-05-02 | 2006-11-02 | Saint-Gobain Ceramics & Plastics, Inc. | Method for making a ceramic article and ceramic extrudate |
| US20080145446A1 (en) * | 2006-12-14 | 2008-06-19 | Chris Johnson | Multi-purpose hand and/or skin cleaner, sanitizer, drug delivery and exercise system |
| EP2207529B1 (en) * | 2007-09-07 | 2014-12-31 | Mati Therapeutics Inc. | Drug cores for sustained release of therapeutic agents |
| TW200927141A (en) * | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| WO2009099586A2 (en) | 2008-02-04 | 2009-08-13 | Duramed Pharmaceuticals, Inc. | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof |
| AU2010256558B2 (en) | 2009-06-03 | 2013-10-03 | Forsight Labs, Llc | Anterior segment drug delivery |
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| GB201115592D0 (en) * | 2011-09-09 | 2011-10-26 | Vivosens Medical Gmbh | Flexible ring pessary |
| RU2740680C2 (ru) | 2011-09-14 | 2021-01-19 | Форсайт Вижн5, Инк. | Глазное вкладочное устройство и способы |
| EP2911623B1 (en) | 2012-10-26 | 2019-08-14 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
| WO2015055789A1 (en) | 2013-10-17 | 2015-04-23 | Bayer Pharma Aktiengesellschaft | INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| ES3009909T3 (en) | 2015-05-13 | 2025-03-31 | Bayer Oy | Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol |
| EP3393452B1 (en) * | 2015-12-21 | 2021-08-04 | Bayer Oy | Method for manufacturing a drug delivery device |
| WO2018202574A1 (en) | 2017-05-04 | 2018-11-08 | Bayer Oy | Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception |
| PE20210506A1 (es) | 2018-07-12 | 2021-03-15 | Prima Temp Inc | Aparatos y metodos de deteccion de temperatura vaginal |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2432870A (en) * | 1944-02-25 | 1947-12-16 | George J Evalt | Plastic ring and method of making the same |
| US2528528A (en) * | 1945-06-15 | 1950-11-07 | Lyon George Albert | Method of and apparatus for forming plastic |
| US2459721A (en) * | 1946-01-26 | 1949-01-18 | Johns Manville | Method of manufacturing gaskets |
| US2670313A (en) * | 1951-01-19 | 1954-02-23 | Richard E Young | Method of making a ring of a length of thermoplastic material |
| US3127363A (en) * | 1955-08-05 | 1964-03-31 | Process for the manufacture of elasto- | |
| US2852424A (en) * | 1957-04-30 | 1958-09-16 | Frank W Reinhart | Reinforced plastic springs |
| US3068531A (en) * | 1957-05-16 | 1962-12-18 | Koiled Kords Inc | Retractile cord and method of making same |
| GB844128A (en) * | 1957-10-21 | 1960-08-10 | Midland Silicones Ltd | Siloxane elastomers |
| US3026569A (en) * | 1959-02-16 | 1962-03-27 | Philip B Keller | Method of fabricating omicron-rings |
| DE1245956B (OSRAM) * | 1964-03-02 | 1967-08-03 | ||
| US3586566A (en) * | 1965-10-21 | 1971-06-22 | Chesterton A W Co | Process of encapsulating an o-ring |
| US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
| US3920805A (en) * | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
| CA1045977A (en) * | 1973-05-17 | 1979-01-09 | Arthur D. Little | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
| US4064027A (en) * | 1973-09-28 | 1977-12-20 | Dow Corning Corporation | UV curable composition |
| IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
| DE2616064A1 (de) * | 1976-04-09 | 1977-10-20 | Schering Ag | Vaginalring iii |
| FR2338128A1 (fr) * | 1976-01-19 | 1977-08-12 | Nortene Sa | Procede de fabrication d'elements helicoidaux en matiere synthetique extrudes, dispositif pour sa mise en oeuvre et elements helicoidaux obtenus |
| US4050975A (en) * | 1976-09-22 | 1977-09-27 | B.W. Darrah, Inc. | O-ring splicing fixture |
| DE3040978A1 (de) * | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
| SU1121153A1 (ru) * | 1982-12-07 | 1984-10-30 | Предприятие П/Я Р-6455 | Способ изготовлени бесконечных резиновых уплотнителей |
| US4720384A (en) * | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
-
1987
- 1987-07-22 FR FR8710363A patent/FR2618329B1/fr not_active Expired - Lifetime
-
1988
- 1988-07-13 GB GB8816638A patent/GB2207355B/en not_active Expired - Lifetime
- 1988-07-19 SE SE8802675A patent/SE500603C2/sv not_active IP Right Cessation
- 1988-07-21 DE DE3824853A patent/DE3824853C2/de not_active Expired - Lifetime
- 1988-07-21 CA CA000572616A patent/CA1298688C/en not_active Expired - Lifetime
- 1988-07-21 IT IT8867688A patent/IT1223709B/it active
- 1988-07-21 DK DK408788A patent/DK171154B1/da not_active IP Right Cessation
- 1988-07-21 ES ES8802306A patent/ES2009987A6/es not_active Expired
- 1988-07-21 US US07/222,441 patent/US4888074A/en not_active Expired - Lifetime
- 1988-07-21 CH CH2792/88A patent/CH675964A5/de not_active IP Right Cessation
- 1988-07-22 JP JP63181942A patent/JP2755392B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3824853C2 (de) | 2000-10-05 |
| DK171154B1 (da) | 1996-07-08 |
| FR2618329B1 (fr) | 1997-03-28 |
| GB2207355B (en) | 1991-01-23 |
| IT8867688A0 (it) | 1988-07-21 |
| DE3824853A1 (de) | 1989-03-02 |
| ES2009987A6 (es) | 1989-10-16 |
| SE8802675D0 (sv) | 1988-07-19 |
| SE8802675L (sv) | 1989-01-23 |
| GB2207355A (en) | 1989-02-01 |
| FR2618329A1 (fr) | 1989-01-27 |
| CA1298688C (en) | 1992-04-14 |
| DK408788D0 (da) | 1988-07-21 |
| GB8816638D0 (en) | 1988-08-17 |
| CH675964A5 (OSRAM) | 1990-11-30 |
| JPS6440419A (en) | 1989-02-10 |
| JP2755392B2 (ja) | 1998-05-20 |
| DK408788A (da) | 1988-07-21 |
| IT1223709B (it) | 1990-09-29 |
| US4888074A (en) | 1989-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4888074A (en) | Therapeutic rings | |
| AU748653B2 (en) | Method for injection molding manufacture of controlled release devices | |
| AU2020244597B2 (en) | Drug release device and use | |
| CN116674198A (zh) | 利用光固化材料的混合式3d打印 | |
| IE42345B1 (en) | Vaginal ring | |
| CH624580A5 (OSRAM) | ||
| RU2541812C2 (ru) | Интравагинальная система доставки лекарственных средств и способ ее изготовления | |
| JPH10265370A (ja) | 制御された放出性複合物の製造方法 | |
| CN1863504A (zh) | 用基于聚氨酯的聚合物制造长效药物递送装置 | |
| HK1041814B (zh) | 藥物導出器具，特別用於孕酮和雌激素的導出 | |
| JP7306939B2 (ja) | 立体物の付加製造用の材料並びにそれの製造法及び使用 | |
| EP0293560A1 (en) | Intraocular lens | |
| CN1367682A (zh) | 药物导出器具,特别用于雄激素的导出 | |
| CN114514254B (zh) | 一种用于形成透明牙齿矫正装置的组合物、透明牙齿矫正装置的制造方法以及通过该方法来制造的透明牙齿矫正装置 | |
| CA3230804A1 (en) | Refillable implantable device for delivering a drug compound | |
| JP2001500306A (ja) | 医療用電気リード線及びその中に使用される強化シリコーンエラストマー組成物 | |
| JPH09225040A (ja) | 制御された放出をする装置の製造方法 | |
| AU731760B2 (en) | Methods for making controlled release devices for pharmaceuticals | |
| US5958317A (en) | Method for manufacturing a controlled-release device | |
| CA1084792A (en) | Vaginal ring iii | |
| JPH1171263A5 (OSRAM) | ||
| JP2020120896A (ja) | バルーンカテーテル | |
| JP6278562B2 (ja) | 医療用ドレインチューブの製造方法並びにクロスヘッドダイ及びクロスヘッド型押出機 | |
| JP2020120767A (ja) | バルーンカテーテルの製造方法 | |
| ATE21331T1 (de) | Verfahren zur herstellung von intrauterinen vorrichtungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |